Skip to main content

Funding Opportunities and Announcements

HIV Prevention Trials Network (HPTN) Call for Concepts: 2021

 

National Institute on Minority Health and Health Disparities (NIMHD) Health Disparities Research Institute Virtual Course, August 9-13, 2021. Apply by March 8, 2021, for early-stage investigators.
 

 

Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) Open date: March 7, 2021. 

 

NIH Launches Funding Opportunities to Recruit Diverse Research Faculty - two funding opportunities with application deadlines of March 1, 2021.

 

National Institute of Diabetes and Digestive Kidney Diseases (NIDDK): Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) and see Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed)

 

HIV, Infectious Disease and Global Health Implementation Research Institute (HIGH IRI): Growing the scientific community using implementation research to advance public health response program. Two-year training and mentorship program. Applications due March 5, 2021. 

 

CDC-RFA-PS21-2104: Partnering and Communicating Together, Department of Health and Human Services, Centers for Disease Control - NCHHSTP There will be two webinars on this opportunity - read more here. 

 

Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed).

 

Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) 

 

New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)

 

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

 

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)  

 

NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) Open for applications Feb. 26, 2021.

 

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities), standard AIDS dates apply. Expires in 2023.

R21 Clinical Trial Optional

R01 Clinical Trial Optional

 

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) 

 

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

 

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

 

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

 

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

 

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation Expires May 8, 2021.

 

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)